Periklis Pappas
Professor
Periklis Pappas
Contact
Telephone
+30 26510 07553
Collaboration schedule
Tuesday 11.00-13.00
Wednesday 11.00-13.00
Thursday 11.00-13.00
Address
Faculty of Medicine
School of Health Sciences
University Campus
45110, Ioannina, Greece
Academic information
O.G.G. of Appointment
1982/Γ'/7-12-2020
Personal webpage
PubMed
Curriculum Vitae
Field
Pharmacology
Research areas
Basic Research
Cancer
Clinical Research
Inflammatory Diseases and Immunity
Courses
Research interests
Indicative publications
- Touloupi K, Küblbeck J, Magklara A, Molnár F, Reinisalo M, Konstandi M, Honkakoski P, Pappas P. The Basis for Strain-Dependent Rat Aldehyde Dehydrogenase 1A7 (ALDH1A7) Gene Expression. Molecular Pharmacology, 96(5):655-663, 2019.
- Tseliou F, Pappas P, Spyrou K, Hrbac J, Prodromidis MI. Lab-on-a-screen-printed electrochemical cell for drop-volume voltammetric screening of flunitrazepam in untreated, undiluted alcoholic and soft drinks. Biosensors and Bioelectronics, 132:136-142, 2019.
- Biziota E, Briasoulis E, Mavroeidis L, Marselos M, Harris AL, Pappas P. Cellular and molecular effects of metronomic vinorelbine and 4-O-deacetylvinorelbine on human umbilical vein endothelial cells. Anti-Cancer Drugs, 27(3):216-224, 2016.
- Stavrinou P, Mavrogiorgou MC, Polyzoidis K, Kreft-Kerekes V, Timmer M, Marselos M, Pappas P. Expression profile of genes related to drug metabolism in human brain tumors. PLoS ONE, 10(11), art. no. 0143285, 2015.
- Mavroeidis L, Sheldon H, Briasoulis E, Marselos M, Pappas P, Harris AL. Metronomic vinorelbine: Anti-angiogenic activity in vitro in normoxic and severe hypoxic conditions, and severe hypoxia-induced resistance to its anti-proliferative effect with reversal by Akt inhibition. International Journal of Oncology, 47(2):455-464, 2015.
- Briasoulis E, Pappas P, Puozzo C, Tolis C, Fountzilas G, Dafni U, Marselos M, Pavlidis N. Dose-ranging study of metronomic oral vinorelbine in patients with advanced refractory cancer. Clinical Cancer Research, 15(20):6454-6461, 2009.
- Pappas P, Karavasilis V, Briasoulis E, Pavlidis N, Marselos M. Pharmacokinetics of imatinib mesylate in end stage renal disease. A case study. Cancer Chemotherapy and Pharmacology, 56(4):358-360, 2005.